FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1633366391> ?p ?o ?g. }

• W1633366391 endingPage "144" @default.
• W1633366391 startingPage "144" @default.
• W1633366391 abstract "Purpose: Investigations, in which oxidized-low density lipoprotein (ox-LDL), serum paraoxonase (PON1) and homocysteine (Hcy) are considered together as important agents involved in the development of oxidative and atherogenic events in non-diabetic hemodialysis (HD) population, are limited. This case-control study was designed to evaluate these parameters in the patients and control subjects and to determine the correlations among the factors. Methods: Forty-nine age- and sex- matched subjects, including 28 non-diabetic HD patients (paired pre-and post-dialysis samples) and 21 control subjects, were enrolled. Ox-LDL and Hcy levels were measured with ELISA and EIA methods, respectively. Arylesterase activity of PON1 was measured by spectrophotometric assay. Results: Compared with the control group, ox-LDL levels were significantly increased both before (p=0.001) and after HD (p=0.036). Arylesterase activity-to-HDL ratio in HD patients was significantly higher than control subjects (p=0.003). Homocysteine levels in the ESRD patients were higher than control subjects both in pre-dialysis and post-dialysis. There was a significant positive correlation (r= 0.25, p= 0.026) between ox-LDL and homocysteine in samples obtained before HD. Logistic regression analysis revealed ox-LDL levels (OR=3.02, p < 0.001) and arylesterase activity/HDL ratio (OR=2.43, p=0.01) to be associated with the increased risk of ESRD. Conclusions: Ox-LDL levels and arylesterase activity/HDL ratio indicated the strongest association with ESRD risk. These factors, especially ox-LDL as an indicator of oxidative stress, may be biomarkers in evaluating the status of non-diabetic ESRD patients. Because of the pathogenic relationship between ox-LDL and homocysteine as nontraditional risk factors of atherosclerosis, therapeutic strategies adopted to reduce them may be useful in decrease of high prevalence of cardiovascular mortality in dialysis patients. In addition, measurement of PON1 activity to HDL ratio is possibly a more valuable biomarker than arylesterase activity alone in non-diabetic ESRD." @default.
• W1633366391 created "2016-06-24" @default.
• W1633366391 creator A5009885856 @default.
• W1633366391 creator A5010743959 @default.
• W1633366391 creator A5035684633 @default.
• W1633366391 creator A5038499873 @default.
• W1633366391 creator A5038698872 @default.
• W1633366391 date "2012-06-01" @default.
• W1633366391 modified "2023-10-14" @default.
• W1633366391 title "Increased oxidized-LDL levels and arylesterase activity/HDL ratio in ESRD patients treated with hemodialysis" @default.
• W1633366391 cites W1871389503 @default.
• W1633366391 cites W1965296996 @default.
• W1633366391 cites W1978272013 @default.
• W1633366391 cites W1989245499 @default.
• W1633366391 cites W1989421917 @default.
• W1633366391 cites W2009038659 @default.
• W1633366391 cites W2010769709 @default.
• W1633366391 cites W2010853786 @default.
• W1633366391 cites W2017976543 @default.
• W1633366391 cites W2021395497 @default.
• W1633366391 cites W2022215662 @default.
• W1633366391 cites W2023328851 @default.
• W1633366391 cites W2041472089 @default.
• W1633366391 cites W2046485996 @default.
• W1633366391 cites W2050776161 @default.
• W1633366391 cites W2057983533 @default.
• W1633366391 cites W2065043905 @default.
• W1633366391 cites W2078621701 @default.
• W1633366391 cites W2079781629 @default.
• W1633366391 cites W2080842315 @default.
• W1633366391 cites W2084075677 @default.
• W1633366391 cites W2085566853 @default.
• W1633366391 cites W2102399845 @default.
• W1633366391 cites W2113832549 @default.
• W1633366391 cites W2116421100 @default.
• W1633366391 cites W2119805244 @default.
• W1633366391 cites W2122115743 @default.
• W1633366391 cites W2125029340 @default.
• W1633366391 cites W2128331632 @default.
• W1633366391 cites W2134605929 @default.
• W1633366391 cites W2136128927 @default.
• W1633366391 cites W2137589680 @default.
• W1633366391 cites W2143592796 @default.
• W1633366391 cites W2148689715 @default.
• W1633366391 cites W2159959895 @default.
• W1633366391 cites W2166233619 @default.
• W1633366391 cites W2182751176 @default.
• W1633366391 cites W2215645018 @default.
• W1633366391 doi "https://doi.org/10.25011/cim.v35i3.16590" @default.
• W1633366391 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22673317" @default.
• W1633366391 hasPublicationYear "2012" @default.
• W1633366391 type Work @default.
• W1633366391 sameAs 1633366391 @default.
• W1633366391 citedByCount "15" @default.
• W1633366391 countsByYear W16333663912012 @default.
• W1633366391 countsByYear W16333663912013 @default.
• W1633366391 countsByYear W16333663912014 @default.
• W1633366391 countsByYear W16333663912015 @default.
• W1633366391 countsByYear W16333663912016 @default.
• W1633366391 countsByYear W16333663912018 @default.
• W1633366391 countsByYear W16333663912020 @default.
• W1633366391 countsByYear W16333663912022 @default.
• W1633366391 countsByYear W16333663912023 @default.
• W1633366391 crossrefType "journal-article" @default.
• W1633366391 hasAuthorship W1633366391A5009885856 @default.
• W1633366391 hasAuthorship W1633366391A5010743959 @default.
• W1633366391 hasAuthorship W1633366391A5035684633 @default.
• W1633366391 hasAuthorship W1633366391A5038499873 @default.
• W1633366391 hasAuthorship W1633366391A5038698872 @default.
• W1633366391 hasBestOaLocation W16333663911 @default.
• W1633366391 hasConcept C104317684 @default.
• W1633366391 hasConcept C126322002 @default.
• W1633366391 hasConcept C134018914 @default.
• W1633366391 hasConcept C135763542 @default.
• W1633366391 hasConcept C185592680 @default.
• W1633366391 hasConcept C2776104379 @default.
• W1633366391 hasConcept C2776151105 @default.
• W1633366391 hasConcept C2776509667 @default.
• W1633366391 hasConcept C2776523773 @default.
• W1633366391 hasConcept C2777090595 @default.
• W1633366391 hasConcept C2778063415 @default.
• W1633366391 hasConcept C2778163477 @default.
• W1633366391 hasConcept C2779978075 @default.
• W1633366391 hasConcept C2780072125 @default.
• W1633366391 hasConcept C2781389560 @default.
• W1633366391 hasConcept C2908647359 @default.
• W1633366391 hasConcept C37501387 @default.
• W1633366391 hasConcept C55493867 @default.
• W1633366391 hasConcept C71924100 @default.
• W1633366391 hasConcept C90924648 @default.
• W1633366391 hasConcept C99454951 @default.
• W1633366391 hasConceptScore W1633366391C104317684 @default.
• W1633366391 hasConceptScore W1633366391C126322002 @default.
• W1633366391 hasConceptScore W1633366391C134018914 @default.
• W1633366391 hasConceptScore W1633366391C135763542 @default.
• W1633366391 hasConceptScore W1633366391C185592680 @default.
• W1633366391 hasConceptScore W1633366391C2776104379 @default.
• W1633366391 hasConceptScore W1633366391C2776151105 @default.

• next